XOMA (NASDAQ:XOMAO – Get Free Report) is expected to release its resultson Thursday, July 30th. Analysts expect XOMA to post earnings of $0.1761 per share and revenue of $13.91 million for the quarter.
XOMA Stock Performance
NASDAQ:XOMAO opened at $25.00 on Tuesday. The company’s 50-day moving average is $25.24 and its two-hundred day moving average is $25.36. XOMA has a 12-month low of $24.86 and a 12-month high of $26.40.
XOMA Dividend Announcement
The company also recently announced a quarterly dividend, which was paid on Tuesday, July 14th. Investors of record on Thursday, July 2nd were given a dividend of $0.5234 per share. The ex-dividend date was Thursday, July 2nd. This represents a $2.09 dividend on an annualized basis and a yield of 8.4%.
XOMA Company Profile
XOMA Corporation is a clinical-stage biotechnology company specializing in the discovery and development of therapeutic antibodies. The company applies its proprietary protein engineering and antibody optimization platform to generate novel drug candidates targeting autoimmune, inflammatory and metabolic diseases. XOMA’s scientific expertise spans antibody discovery, engineering, in vitro and in vivo testing, and early‐stage clinical development.
In addition to advancing its own pipeline of antibody candidates, XOMA collaborates with pharmaceutical and biotechnology partners to provide research and development services.
Featured Articles
- Five stocks we like better than XOMA
- AirJoule’s Kubota Deal Is a Major Validation—But the Hard Part Comes Next
- Dividend Stocks May Be the Quiet Rotation Trade Investors Are Missing Now
- Refiner Stocks Are Near Record Highs—Can Iran-Driven Margins Keep Them There?
- Verizon May Be an AI Infrastructure Stock Hiding in Plain Sight
Receive News & Ratings for XOMA Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for XOMA and related companies with MarketBeat.com's FREE daily email newsletter.
